Vaccines and Atrial Fibrillation: A Real-World Pharmacovigilance Study Based on Vaccine Adverse Event Reporting System.

Al-Yafeai, Zaki; Ghoweba, Mohamed; Aziz, David; Ananthaneni, Anil; Sabayon, Muhie Dean

Al-Yafeai, Zaki; Ghoweba, Mohamed; Aziz, David; Ananthaneni, Anil; Sabayon, Muhie Dean.

Al-Yafeai Z; Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Shreveport, LA.
Ghoweba M; Department of Medicine, CHRISTUS Good Shepherd/Texas A&M College of Medicine, Longview, TX.
Aziz D; Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Shreveport, LA.
Ananthaneni A; Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Shreveport, LA.
Sabayon MD; Department of Medicine, CHRISTUS Good Shepherd/Texas A&M College of Medicine, Longview, TX.

Am J Ther ; 30(2): 151-153, 2023.

Article in English | MEDLINE | ID: covidwho-2248730

Subject(s)

Atrial Fibrillation; Vaccines; Humans; Atrial Fibrillation/drug therapy; Atrial Fibrillation/chemically induced; Pharmacovigilance; Vaccines/adverse effects; Adverse Drug Reaction Reporting Systems

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Atrial Fibrillation / Vaccines Topics: Vaccines Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2023 Document Type: Article Affiliation country: MJT.0000000000001546

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google